Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Albireo PharmaMerusCytomX TherapeuticsAeglea Bio TherapeuticsAvedro
Price Information
Current Price$25.95$15.82$8.41$9.06$22.99
52 Week RangeBuyBuyBuyBuyHold
Beat the Market™ Rank
Overall Score1.
Analysis Score3.
Community Score2.
Dividend Score0.
Ownership Score1.
Earnings & Valuation Score0.
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyHold
Consensus Price Target$52.60$20.67$12.38$13.33$25.00
% Upside from Price Target102.70% upside30.64% upside47.15% upside47.17% upside8.74% upside
Trade Information
Market Cap$388.72 million$459.44 million$386.21 million$404.01 million$402.79 million
Average Volume97,745107,860665,738461,14089,666
Sales & Book Value
Annual Revenue$9.64 million$31.13 million$57.49 million$3.89 million$27.67 million
Price / Sales40.3214.766.72103.8514.56
Price / CashN/AN/AN/AN/AN/A
Book Value$7.34 per share$5.61 per share$1.12 per share$2.07 per share$2.52 per share
Price / Book3.542.827.514.389.12
Net Income$-62,720,000.00$-55,150,000.00$-102,240,000.00$-78,250,000.00$-25,120,000.00
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
Net Margins-730.55%-225.21%-97.83%N/A-81.59%
Return on Equity (ROE)-72.82%-62.96%-99.72%-113.09%-162.76%
Return on Assets (ROA)-44.27%-27.54%-19.52%-87.34%-47.16%
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt-to-Equity RatioN/AN/A0.35%0.11%0.46%
Current Ratio10.45%6.34%3.77%3.17%8.41%
Quick Ratio10.45%6.34%3.77%3.17%7.89%
Ownership Information
Institutional Ownership Percentage69.69%62.02%78.59%46.09%69.05%
Insider Ownership Percentage5.00%7.40%5.80%12.60%N/A
Shares Outstanding14.98 million29.04 million45.92 million44.59 million17.52 million
Next Earnings Date8/13/2020 (Estimated)8/17/2020 (Estimated)8/5/2020 (Estimated)8/4/2020 (Estimated)N/A
OptionableOptionableNot OptionableOptionableOptionableNot Optionable

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.